儿童咽喉反流病与分泌性中耳炎:系统综述与荟萃分析
COM患儿中胃食管反流病累积患病率估计为50.7%,27.6%报告咽反流事件;中耳积液胃蛋白酶汇总检出率为72.5%(95%CI 53.7%-88.0%),ELISA法为85.6%而酶法为17.9%。OME患者与对照的胃蛋白酶浓度合并标准化均数差为大且显著(Hedges' g=1.92,95%CI 0.58-3.25,P=.005)。
要点
- 儿童COM/ROM患者中耳积液可检出胃十二指肠来源生物标志物
- 中耳积液胃蛋白酶检出率因检测方法而异,ELISA法明显高于酶法
- 现有研究在诊断标准与生物标志物测量上异质性大
核心结论
- 儿童慢性分泌性中耳炎与复发性中耳炎的中耳积液中存在胃十二指肠生物标志物。
- 未来需开展前瞻性横向研究,探索有明确咽反流事件患儿积液中的碱性激活酶与胆盐。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Scopus和Cochrane数据库。
- 采用随机效应模型进行两项荟萃分析:估计中耳积液胃蛋白酶/胃蛋白酶原检出合并患病率,以及用标准化均数差(Hedges' g)比较COM/ROM患者与对照的胃蛋白酶浓度。
主要发现
- COM患儿中胃食管反流病累积患病率估计为50.7%,27.6%的儿童报告咽反流事件。
- 胃蛋白酶检出率在ELISA法为85.6%,而酶法为17.9%。
- OME患者与对照的胃蛋白酶浓度合并标准化均数差为大且显著(Hedges' g=1.92,95%CI 0.58-3.25,P=.005)。
- 3项研究评估碱性激活胃十二指肠介质,胰蛋白酶检出率范围为39.6%至100%,胆盐为32%至42%。
临床怎么用
- 对儿童COM/ROM评估时,可考虑咽喉反流作为共病因素,但诊断标准尚不统一。
- 解读中耳积液胃蛋白酶检出率时需注意检测方法差异,ELISA法阳性率明显高于酶法。
局限性
- COM/ROM与反流病的诊断标准、胃十二指肠生物标志物测量及结局指标存在显著异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore the relationship between recurrent otitis media (ROM), chronic media otitis with effusion (COM), and laryngopharyngeal reflux disease (LPRD) in pediatric populations. DATA SOURCES: PubMed, Scopus, and Cochrane databases. REVIEW METHODS: Two investigators independently screened papers with PRISMA guidelines considering the following primary outcomes: LPRD prevalence in pediatric ROM and COM, diagnostic methods used, and detection rates of gastroduodenal markers in middle ear effusions. Two random-effects meta-analyses were performed to estimate the pooled prevalence of pepsin/pepsinogen detection in middle ear effusions and to compare pepsin concentrations between COM/ROM patients and controls using standardized mean differences (Hedges' g). RESULTS: Twenty-eight studies were included (2070 pediatric patients). The cumulated gastroesophageal reflux disease prevalence in COM children was estimated to 50.7%, while 27.6% of children reported pharyngeal reflux events. Fifteen studies measured pepsin in effusions, reporting a pooled detection prevalence of 72.5% (95% CI: 53.7%-88.0%), rising to 85.6% with ELISA-based methods versus 17.9% with enzymatic assays. The pooled standardized mean difference in pepsin concentration between OME patients and controls was large and significant (Hedges' g = 1.92, 95% CI: 0.58-3.25, P = .005). Alkaline-activated gastroduodenal mediators were assessed in 3 studies, with detection rates ranging from 39.6% to 100% for trypsin and from 32% to 42% for bile salts. Substantial heterogeneity was found for COM/ROM and reflux disease diagnostic criteria, gastroduodenal biomarker measurements, and outcomes. CONCLUSION: Gastroduodenal biomarkers are present in middle ear effusions of children with COM and ROM. Future prospective transversal studies exploring alkaline-activated enzymes and bile salts in effusion of children with documented pharyngeal reflux events are needed.
引用
- Lechien JR, Briganti G. Pediatric Laryngopharyngeal Reflux Disease and Otitis Media With Effusion: A Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2026. PMID: 42867255. doi:10.1002/ohn.70488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。